From the AGA Journals
From the Journals
Long-term budesonide oral suspension well tolerated in EoE
In all, 42% of initial responders maintained a histologic response.
From the AGA Journals
AGA Clinical Practice Update: Functional gastrointestinal symptoms in patients with inflammatory bowel disease
It’s essential to determine whether the symptoms are caused by inflammation or another etiology that can be addressed separately.
From the Journals
AGA Guideline: Treatment of mild to moderate ulcerative colitis
Mesalamine and diazo-bonded 5-aminosalicylic acid are still the primary drugs recommended for treatment.
From the AGA Journals
Dietary aluminum may trigger IBS
Aluminum ingestion triggers visceral hypersensitivity in rats, suggesting that dietary levels of aluminum may contribute to development of...
From the Journals
Childhood inflammatory bowel disease linked to increased mortality
The risk of death was three- to fivefold higher than that in the general population.
From the Journals
Metachronous advanced neoplasia linked to diminutive polyp number, not histology
Metachronous advanced neoplasia was diagnosed in similar proportions of patients with and without high-risk diminutive polyps.
From the Journals
Studies support vedolizumab-calcineurin inhibitor combinations but not accelerated infliximab therapy for refractory UC
Rates of colectomy were similar whether patients received induction immunotherapy with infliximab at weeks 0, 2, and 6, or on an accelerated...
From the Journals
Study supports swallowed topical steroids as maintenance for eosinophilic esophagitis
Rates of clinical remission were 16.1% and 1.3%, respectively (P less than .001).
From the Journals
Clinical Guidance: Thiopurine agents for the treatment of IBD
Thiopurines can reduce steroid use and increase anti–tumor necrosis factor blood values.
From the AGA Journals
Vedolizumab, tofacitinib induced rapid improvements in IBD symptoms
Two recent studies highlight the ability of vedolizumab and tofacitinib to rapidly improve symptoms reported by patients with inflammatory bowel...